We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Livanova | LSE:LIVN | London | Ordinary Share | GB00BYMT0J19 | ORD GBP1.00 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMLIVN
LivaNova Annual Report Form 10-K filing
London, March 1, 2017 - LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) ("LivaNova" or the "Company"), a market-leading medical technology company, today announced that it filed an Annual Report on Form 10-K under the U.S. Securities Exchange Act of 1934 for LivaNova for the period January 1, 2016 to December 31, 2016 ("Form 10-K") with the U.S. Securities Exchange Commission (the "SEC") on 1 March, 2017. The Form 10-K can be found on the SEC's website at www.sec.gov and in the Investor Relations section of the Company's website at www.livanova.com.
A copy of the Form 10-K has been submitted to the National Storage Mechanism on the date of this announcement and is, or will be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova's advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London and with a presence in more than 100 countries worldwide, the company employs approximately 4,600 employees.
LivaNova operates as three business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management, with operating headquarters in Mirandola (Italy), Houston (U.S.A.) and Clamart (France), respectively.
For more information, please visit www.livanova.com, or contact:
Catherine Moroz Company Secretariat Phone: +44 (0) 203 325 0662e-mail: company.secretariat@livanova.com
Karen King Vice President, Investor Relations & Corporate Communications Phone: +1 (281) 228-7262Email: corporate.communications@livanova.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170301006265/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
March 01, 2017 12:56 ET (17:56 GMT)
1 Year Livanova Chart |
1 Month Livanova Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions